Transform: Form improves substance

Form and formulation have hardly been the focus of sexy technology startups, leaving the field a low tech backwater. As a result, Transform Pharmaceuticals Inc. says it has the field virtually to itself, and it plans to use its high throughput technologies to improve R&D productivity, improve existing drugs and resuscitate failed compounds.

The idea for TransForm - R&D productivity enhancement - was conceived at Millennium Pharmaceuticals Inc. (MLNM, Cambridge, Mass.), which owns 7% of the company.

"The question is,

Read the full 793 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers